Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Amortization of Deferred Charges (2019 - 2021)

Utah Medical Products has reported Amortization of Deferred Charges over the past 3 years, most recently at $11000.0 for Q3 2021.

  • Quarterly results put Amortization of Deferred Charges at $11000.0 for Q3 2021, up 10.0% from a year ago — trailing twelve months through Sep 2021 was $42000.0 (up 10.53% YoY), and the annual figure for FY2020 was $39000.0, up 2.63%.
  • Amortization of Deferred Charges for Q3 2021 was $11000.0 at Utah Medical Products, roughly flat from $11000.0 in the prior quarter.
  • Over the last five years, Amortization of Deferred Charges for UTMD hit a ceiling of $11000.0 in Q2 2021 and a floor of $9000.0 in Q2 2019.
  • Median Amortization of Deferred Charges over the past 3 years was $10000.0 (2019), compared with a mean of $9909.1.
  • Peak annual rise in Amortization of Deferred Charges hit 11.11% in 2020, while the deepest fall reached 10.0% in 2020.
  • Utah Medical Products' Amortization of Deferred Charges stood at $9000.0 in 2019, then increased by 11.11% to $10000.0 in 2020, then increased by 10.0% to $11000.0 in 2021.
  • The last three reported values for Amortization of Deferred Charges were $11000.0 (Q3 2021), $11000.0 (Q2 2021), and $10000.0 (Q1 2021) per Business Quant data.